Heartflow (HTFL) director granted 16,075 stock options at $32.05

Rhea-AI Filing Summary

Heartflow, Inc. director Jeffrey C. Lightcap received a grant of stock options covering 16,075 shares of common stock. The options have an exercise price of $32.05 per share and expire on June 16, 2036.

According to the grant terms, the option will vest in full on the earlier of the day prior to Heartflow’s annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to Mr. Lightcap’s continued service through that date. Following this grant, he holds options for 16,075 underlying shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lightcap Jeffrey C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	16,075	$32.05	$515K

Holdings After Transaction: Stock Option — 16,075 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 16,075 shares Exercise price: $32.05 per share Expiration date: June 16, 2036 +2 more

5 metrics

Option grant size 16,075 shares Stock option covering Heartflow common stock

Exercise price $32.05 per share Stock option exercise price

Expiration date June 16, 2036 Option expiry

Underlying shares 16,075 shares Common stock underlying the option

Post-grant derivative holdings 16,075 shares Total shares underlying options held directly after grant

Key Terms

Stock Option, Common Stock, grant/award acquisition, annual meeting of shareholders, +1 more

5 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

annual meeting of shareholders financial

"the day prior to Heartflow, Inc.'s annual meeting of shareholders in 2027"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

exercise price financial

"conversion_or_exercise_price: "32.0500""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lightcap Jeffrey C

(Last) (First) (Middle)

C/O HEARTFLOW, INC.

135 MAIN STREET, SUITE 1000

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$32.05	06/16/2026		A		16,075		(1)	06/16/2036	Common Stock	16,075	$32.05	16,075	D

Explanation of Responses:

1. The option will vest in full on the earlier of the day prior to Heartflow, Inc.'s annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.

	/s/ Nga Van by power of attorney	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Heartflow (HTFL) report for Jeffrey C. Lightcap?

Heartflow reported that director Jeffrey C. Lightcap received a stock option grant for 16,075 shares of common stock. The option is a compensation-related award, not an open-market trade, and gives him the right to buy shares at a fixed exercise price.

How many Heartflow (HTFL) shares are covered by the new option grant?

The option grant covers 16,075 shares of Heartflow common stock. These shares are the underlying securities Mr. Lightcap may acquire by exercising the option, subject to the vesting schedule and the stated expiration date in 2036.

What is the exercise price and expiration date of Jeffrey Lightcap’s Heartflow options?

The stock options have an exercise price of $32.05 per share and expire on June 16, 2036. This means Mr. Lightcap can choose to buy the underlying shares at $32.05 any time after vesting and before the expiration date.

When do Jeffrey Lightcap’s Heartflow stock options vest?

The options will vest in full on the earlier of the day before Heartflow’s 2027 annual shareholder meeting and the first anniversary of the grant date. Vesting is conditioned on Mr. Lightcap’s continued service with the company through that vesting date.

Did Jeffrey Lightcap buy or sell Heartflow (HTFL) shares in this Form 4?

This Form 4 reports a grant of stock options as compensation, not a market purchase or sale of shares. The transaction is coded as an acquisition (grant or award), giving Mr. Lightcap the right to acquire shares in the future upon exercise.

How many Heartflow derivative securities does Jeffrey Lightcap hold after this grant?

After this grant, Mr. Lightcap holds stock options covering 16,075 shares of Heartflow common stock directly. This reflects his derivative position from this single reported grant and shows the number of underlying shares tied to the options.